- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 495/18 - Bridged systems
Patent holdings for IPC class C07D 495/18
Total number of patents in this class: 47
10-year publication summary
|
5
|
3
|
3
|
7
|
6
|
7
|
3
|
5
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of Columbia University in the City of New York | 3556 |
4 |
| Teijin Limited | 1233 |
4 |
| Fred Hutchinson Cancer Center | 432 |
4 |
| Mutabilis | 27 |
3 |
| University of Washington | 2294 |
3 |
| Sanofi | 4000 |
3 |
| Abbvie Inc. | 1793 |
2 |
| Oricula Therapeutics LLC | 2 |
2 |
| Rhode Island Board of Education, State of Rhode Island and Providence Plantations | 14 |
2 |
| Zomagen Biosciences Ltd | 15 |
2 |
| ExxonMobil Research And Engineering Company | 2597 |
1 |
| Abbott Laboratories | 2417 |
1 |
| FUJIFILM Corporation | 29172 |
1 |
| AbbVie Deutschland GmbH & Co. KG | 259 |
1 |
| Duk San Neolux Co., Ltd. | 632 |
1 |
| Fred Hutchinson Cancer Research Center | 357 |
1 |
| Gilead Sciences, Inc. | 2019 |
1 |
| Icahn School of Medicine at Mount Sinai | 927 |
1 |
| Lixte Biotechnology, Inc. | 63 |
1 |
| South China Sea Institute of Oceanology, Chinese Academy of Sciences | 66 |
1 |
| Other owners | 8 |